Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin

Rauch, A; Egger, M; Reichen, J; Furrer, H; Swiss, HIV Cohort Study (2005). Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin. Journal of acquired immune deficiency syndromes JAIDS, 38(2), pp. 238-40. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/01.qai.0000148535.97081.72

Full text not available from this repository.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Furrer, Hansjakob

ISSN:

0894-9255

ISBN:

15671812

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:00

Last Modified:

05 Dec 2022 14:18

Publisher DOI:

10.1097/01.qai.0000148535.97081.72

PubMed ID:

15671812

Web of Science ID:

000226736800018

URI:

https://boris.unibe.ch/id/eprint/25715 (FactScience: 60793)

Actions (login required)

Edit item Edit item
Provide Feedback